Nausea and vomiting in HIV/AIDS

Gastroenterology Nursing

Volumn 34, Issue 1, 2011, Pages 15-24

  Anastasi, Joyce K ^a   Capili, Bernadette ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG HYPERSENSITIVITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NAUSEA; VOMITING;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG HYPERSENSITIVITY; HIV INFECTIONS; HUMANS; NAUSEA; VOMITING;

EID: 79952267065     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/SGA.0b013e31820b256a     Document Type: Review

References (43)

1. Bonfanti, P., Valsecchi, L., Parazzini, F., Carradori, S., Pusterla, L., Fortuna, P., et al. (2000). Incidence of adverse reactions in HIV patients treated with protease inhibitors: A cohort study. Journal of Acquired Immune Deficiency Syndromes, 23(3), 236-245. (Pubitemid 30331242)
2. Bongiovanni, M., & Tordato, F. (2007). Steatohepatitis in HIV-infected subjects: Pathogenesis, clinical impact and implications in clinical management. Current HIV Research, 5, 490-498.
3. Capili, B., & Anastasi, J. K. (1998). A symptom review: Nausea and vomiting in HIV. Journal of the Association of Nurses in AIDS Care, 9(6), 47-56. (Pubitemid 128708579)
4. Capili, B., & Anastasi, J. K. (2009). Nausea and vomiting. In B. Swanson (Ed.), ANAC's core curriculum for HIV/AIDS nursing (3rd ed., pp. 167-170). Sudbury, MA: Jones and Barlett.
5. Carpenter, C., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hammer, S., et al. (2000). Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA panel. JAMA, 283(3), 381-390. (Pubitemid 30051757)
6. Carr, A., & Amin, J. (2009). Efficacy and tolerability of initial antiretroviral therapy: A systematic review. AIDS, 23(3), 343-353
7. Carr, A., & Cooper, D. A. (2000). Adverse effects of antiretroviral therapy. Lancet, 356(9239), 1423-1430.
8. Chariot, P., Bourokba, N., Monnet, I., & Gherardi, R. (2002). Hyperlactatemia and human immunodeficiency virus infection: Lessons from the era of antiretroviral monotherapy. Antimicrobial Agents & Chemotherapy, 46(11), 3683. (Pubitemid 35192953)
9. Clay, P. (2002). The abacavir hypersensitivity reaction: A review. Clinical Therapeutics, 24(10), 1502-1514.
10. Food & Drug Administration. (2010). Videx/Videx EC (didanosine): Labeling revision - Risk of non-cirrhotic portal hypertension. Silver Spring, MD: Author. http://www.fda.gov/safety/medwatch/safetyinformation/ safetyalertsforhumanmedicalproducts/ucm199343.htm
11. Fischer-Rasmussen, W., Kjaser, S. K., Dahl, C., & Asping, U. (1991). Ginger treatment of hyperemesis gravidarum. European Journal of Obstetrics and Gynecology, 38, 19-24.
12. Garrett, K., Tsuruta, K., Walker, S., Jackson, S., & Sweat, M. (2003). Managing nausea and vomiting: Current strategies. Critical Care Nurse, 23(1), 31-50.
13. Gilbert, D., Moellering, R. L., Eliopoulos, G. M., Chambers, H. F., & Saag, M. S. (Eds.). (2009). Sanford guide to antimicrobials therapy 2009. New Hyde, VT: Antimicrobial Therapy.
14. Gonzalez de Requena, D., Nunez, M., Jimenez-Nacher, I., & Soriano, V. (2002). Liver toxicity caused by nevirapine. AIDS, 16(2), 290-291. (Pubitemid 34118577)
15. Highleyman, L. (2002). Managing nausea, vomiting, and diarrhea. BETA Bulletin of Experimental Treatments for AIDS: A Publication of the San Francisco AIDS Foundation, 15(2), 29-39.
16. Johnson, M., Stallworth, T., & Neilands, T. B. (2003). The drugs or the disease? Causal attributions of symptoms held by HIV-positive adults on HAART. AIDS and Behavior, 7, 109-117. (Pubitemid 36781506)
17. Karus, D., Raveis, V. H., Alexander, C., Hanna, B., Selwyn, P., Marconi, K., et al. (2005). Patient reports of symptoms and their treatment at three palliative care projects servicing individuals with HIV/AIDS. Journal of Pain and Symptom Management, 30(5), 408-417. (Pubitemid 41718961)
18. Konturek, J. (1997). Disturbed gastric motor activity in patients with human immunodeficiency virus infection. Scandinavian Journal of Gastroenterology, 32(3), 221.
19. Lacy, C., Armstrong, L. L., Goldman, H. P., & Lance, L. L. (Eds.). (2009). Lexi-Comp drug information handbook. Hudson, OH: Lexi-Comp.
20. Lehne, R. A., Moore, L. A., Crosby L. J., & Hamilton, D. B. (1998). Pharmacology for nursing care. Philadelphia, PA: WB Saunders.
21. Lucas, G., Chaisson, R. E., & Moore, R. D. (1999). Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Annals of Internal Medicine, 131(2), 81-87. (Pubitemid 29340558)
22. Mathews, W., McCutchan, J. A., Asch, S., Turner, B. J., Gifford, A. L., Kuromiya, K., et al. (2000). National estimates of HIV-related symptom prevalence from the HIV cost and services utilization study. Medical Care, 38(7), 750-762.
23. McKenzie, R. (2009). Complications of the gastrointestinal/hepatobiliary system: Nausea/vomiting. Johns Hopkins Point-of-Care Information Technology HIV Guide. Retrieved December 12, 2010, from http://www.hopkins-aids.edu/diagnosis/ organ-system/gastrointestinal-hepatobiliary/nausea-vomiting.html? contentInstanceId=9282
24. Michailidis, C., Pozniak, A. L., Mandalia, S., Basnayake, S., Nelson, M. R., & Gazzard, B. G. (2005). Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis. Antiviral Therapy, 10(3), 417-422. (Pubitemid 41151019)
25. Mocroft, A., Brettle, R., Kirk, O., Blaxhult, A., Parkin, J. M., Antunes, F., et al. (2002). Changes in the cause of death among HIV positive subjects across Europe: Results from the EuroSIDA study. AIDS, 16(12), 1663-1671. (Pubitemid 34921112)
26. National Association of People with AIDS. (2008). Managing side effects http://napwa.org.au//resource/managing-side-effects. Retrieved September 23, 2009, from http://napwa.org.au/resource/managing-side-effects/nausea-vomiting
27. Neild, P., Nijran, K. S., Yazaki, E., Evans, D. F., Wingate, D. L., Jewkes, R., et al (2000). Delayed gastric emptying in human immunodeficiency virus infection. Digestive Diseases and Sciences, 45(8), 1491-1499.
28. O'Brien, B., Relyea, M. J., & Taerum, T. (1996). Efficacy of P6 acupressure in the treatment of nausea and vomiting during pregnancy. American Journal of Obstetrics and Gynecology, 174(2), 708-715. (Pubitemid 26070169)
29. Panel on Antiretroviral Guidelines for Adults and Adolescents. (2009). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (pp. 1-161). Bethesda, MD: National Institutes of Health, Department of Health and Human Services.
30. Parkman, H. (2002). New advances in the diagnosis and management of nausea and vomiting. Case Manager, 13(2), 83-87.
31. Quigley, E., Hasler, W. L., & Parkman, H. P. (2001). AGA Technical review on nausea and vomiting. Gastroenterology, 120(1), 263-286. (Pubitemid 32061891)
32. Reynolds, N., & Neidig, J. L. (2002). Characteristics of nausea reported by HIV-infected patients initiating combination antiretroviral regimens. Clinical Nursing Research, 11(1), 71-88.
33. Rivero, A., Mira, J. A., & Pineda, J. A. (2007). Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors. Journal of Antimicrobial Chemotherapy, 59(3), 342-346. (Pubitemid 47073440)
34. Seidlin, M., Lambert, J. S., Dolin, R., & Valentine, F. T. (1992). Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine. AIDS, 6(8), 831-836.
35. Shelke, A., Mustian, K. M., & Morrow, G. R. (2004). The pathophysiology of treatment-related nausea and vomiting in cancer patients: Current models. Indian Journal of Physiological Pharmacology, 48(3), 256-268.
36. Sherr, L., Harding, R., Lampe, F., Johnson, M., Anderson, J., Zetler, S., et al. (2009). Clinical and behavioural aspects of aging with HIV infection. Psychology, Health and Medicine, 14, 273-279.
37. Sontakke, S., Thawani, V., & Naik, M. (2003). Ginger as an antiemetic in nausea and vomiting induced by chemotherapy: A randomized, cross-over, double blind study. Indian Journal of Pharmacology, 35, 32-36. (Pubitemid 36187471)
38. Spiller, R. C. (2001). ABC of the upper gastrointestinal tract: Anorexia, nausea, vomiting, and pain. BMJ, 323(7325), 1354-1357.
39. Stekler, J., Maenza, J., Stevens, C., Holte, S., Malhotra, U., McElrath, M. J., et al. (2006). Abacavir hypersensitivity reaction in primary HIV infection. AIDS, 20(9), 1269-1274. (Pubitemid 44030375)
40. Thomas, A. M. & Mkandawire, S. C. (2006). The impact of nutrition on physiologic changes in persons who have HIV. Nursing Clinics of North America, 41(3), 455-468. (Pubitemid 44189978)
41. Wilcox, C., & Saag, M. S. (2008). Gastrointestinal complications of HIV infection: Changing priorities in the HAART era. Gut, 57(6), 861-870. (Pubitemid 351716983)
42. Woolridge, E., Barton, S., Samuel, J., Osorio, J., Dougherty, A., & Holdcroft, A. (2005). Cannabis use in HIV for pain and other medical symptoms. Journal of Pain and Symptom Management, 29(4), 358-367. (Pubitemid 40602516)
43. Yuan, C., Wang, C. Z., Mehendale, S., Aung, H., Foo, A., & Israel, R. (2009). Protease inhibitor-induced nausea and vomiting is attenuated by a peripherally acting, opioid-receptor antagonist in a rat model. AIDS Research and Therapy, 6(1), 19.